Renhe Pharmacy Co Ltd (000650) — Capital Reinvestment Ratio
Latest as of September 2025:
0.07x
Renhe Pharmacy Co Ltd (000650) has a Capital Reinvestment Ratio of 0.07x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥188.23 Million) in capital expenditures (CN¥13.71 Million). See 000650 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.07x
Capex / Operating Cash Flow
Operating Cash Flow
CN¥188.23 Million
CNY
Capital Expenditures
CN¥13.71 Million
CNY
Data as of
Sep 2025
Most recent filing
Renhe Pharmacy Co Ltd Capital Reinvestment Ratio (1998–2025)
This chart tracks Renhe Pharmacy Co Ltd's Capital Reinvestment Ratio across 25 annual periods.
Annual Capital Reinvestment Ratio for Renhe Pharmacy Co Ltd (1998–2025)
Year-by-year Capital Reinvestment Ratio for Renhe Pharmacy Co Ltd from 1998 to 2025. For live market cap and broader valuation context, see market cap of Renhe Pharmacy Co Ltd.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.09x | CN¥851.31 Million | CN¥74.59 Million | ▼ -82.9% |
| 2024 | 0.51x | CN¥557.26 Million | CN¥285.72 Million | ▲ +37.3% |
| 2023 | 0.37x | CN¥499.47 Million | CN¥186.55 Million | ▲ +114.5% |
| 2022 | 0.17x | CN¥1.27 Billion | CN¥221.09 Million | ▼ -72.9% |
| 2021 | 0.64x | CN¥777.72 Million | CN¥499.78 Million | ▲ +156.5% |
| 2020 | 0.25x | CN¥871.13 Million | CN¥218.21 Million | ▲ +20.6% |
| 2019 | 0.21x | CN¥693.97 Million | CN¥144.10 Million | ▲ +68.6% |
| 2018 | 0.12x | CN¥569.45 Million | CN¥70.12 Million | ▲ +40.7% |
| 2017 | 0.09x | CN¥497.86 Million | CN¥43.58 Million | ▼ -23.7% |
| 2016 | 0.11x | CN¥522.08 Million | CN¥59.92 Million | ▼ -35.5% |
| 2015 | 0.18x | CN¥434.77 Million | CN¥77.41 Million | ▼ -52.7% |
| 2014 | 0.38x | CN¥365.27 Million | CN¥137.54 Million | ▼ -14.6% |
| 2013 | 0.44x | CN¥213.36 Million | CN¥94.08 Million | ▼ -66.5% |
| 2012 | 1.32x | CN¥183.97 Million | CN¥242.10 Million | ▲ +116.5% |
| 2011 | 0.61x | CN¥166.93 Million | CN¥101.47 Million | ▲ +176.7% |
| 2010 | 0.22x | CN¥130.07 Million | CN¥28.58 Million | ▼ -24.7% |
| 2009 | 0.29x | CN¥200.58 Million | CN¥58.55 Million | ▲ +50.5% |
| 2008 | 0.19x | CN¥62.14 Million | CN¥12.05 Million | ▲ +50.6% |
| 2007 | 0.13x | CN¥35.40 Million | CN¥4.56 Million | ▼ -20.6% |
| 2006 | 0.16x | CN¥235.28 Million | CN¥38.17 Million | ▼ -87.9% |
| 2004 | 1.34x | CN¥17.55 Million | CN¥23.56 Million | ▲ +421.9% |
| 2002 | 0.26x | CN¥27.99 Million | CN¥7.20 Million | ▼ -97.1% |
| 2001 | 8.85x | CN¥3.42 Million | CN¥30.24 Million | ▲ +1553.2% |
| 1999 | 0.54x | CN¥67.37 Million | CN¥36.08 Million | ▼ -40.6% |
| 1998 | 0.90x | CN¥14.48 Million | CN¥13.04 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow